David Steel
David Steel

CFO

CHIEF FINANCIAL OFFICER

David is a Chartered Accountant with extensive international and capital markets experience gained from senior finance roles in large multinational and SME organizations.

Prior to joining Small Pharma, he spent six years as CFO of Feronia Inc., a TSXV listed African agribusiness, where he led successful debt and equity financings of over U.S.$140 million. 

Previously, he was Director of Finance for Misys plc, a multinational technology business supplying software to the global financial services sector, where he managed a global finance team of 70+ people located in 11 countries. As well as managing the global finance function, he played an active operational role and managed the integration of a £365 million multinational acquisition. 

Other roles include Group Financial Controller for Fuller, Smith & Turner plc, a UK listed brewer and pub company, and head of Financial Planning and Analysis and Financial Systems at Inchcape plc, a leading global premium automotive group.

David holds a BA degree from Abertay University in Scotland and is qualified as a Chartered Accountant in Edinburgh.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: